background
acut
respiratori
distress
syndrom
ard
induc
pandem
influenza
viru
wide
report
consid
main
caus
death
critic
ill
patient
infect
howev
anim
model
develop
ard
caus
infect
viru
present
mous
model
ard
induc
viru
methodolog
princip
find
mice
inocul
influenza
variant
mutat
hemagglutinin
clinic
symptom
record
everi
day
lung
injuri
assess
lung
water
content
histopatholog
observ
arteri
blood
ga
leukocyt
count
bronchial
alveolar
lavag
fluid
blood
viru
titer
cytokin
level
lung
measur
variou
time
postinocul
mice
infect
viru
show
typic
ard
symptom
character
lethal
day
postinocul
highli
edemat
lung
inflammatori
cellular
infiltr
alveolar
interstiti
edema
lung
hemorrhag
progress
sever
hypoxemia
elev
level
proinflammatori
cytokin
chemokin
conclusionssignific
result
suggest
success
establish
ard
mous
model
induc
virul
variant
without
previou
adapt
may
benefit
evalu
pathogenesi
therapi
human
ard
caus
viru
novel
influenza
viru
swine
origin
emerg
among
human
mexico
spring
rapidli
spread
worldwid
pandem
prompt
world
health
organ
rais
alert
level
highest
rate
six
pandem
phase
within
month
august
offici
declar
diseas
postpandem
period
howev
still
circul
among
human
togeth
season
virus
although
influenza
case
caus
viru
infect
typic
display
mild
upper
respiratori
tract
syndrom
case
progress
sever
pneumonia
acut
respiratori
distress
syndrom
ard
mani
studi
shown
ard
caus
viru
result
mortal
regard
major
caus
death
viru
infect
ard
result
acut
injuri
lung
tissu
commonli
result
sepsi
trauma
sever
pulmonari
infect
infecti
factor
virus
becom
one
import
caus
ard
human
clinic
case
establish
anim
model
reveal
pathogenesi
patholog
featur
ard
induc
differ
viral
pathogen
distinct
howev
knowledg
pathogenesi
viru
especi
ard
induc
viru
still
limit
hinder
therapeut
strategi
therefor
necessari
evalu
pathogenesi
ard
caus
viru
infect
appropri
anim
model
assess
potenti
therapi
mice
good
model
evalu
pathogenesi
antivir
therapi
influenza
pneumonia
due
gener
fidel
ill
mice
human
diseas
moreov
mous
model
ard
caus
highli
pathogen
avian
influenza
viru
infect
well
establish
typic
viru
effici
replic
mous
lung
without
prior
host
adapt
howev
caus
moder
lung
lesion
mortal
even
inocul
high
dose
pfu
thu
typic
virus
may
abl
induc
ard
mous
model
present
studi
use
virul
variant
viru
isol
pig
possess
virulenceassoci
mutat
establish
ard
mous
model
model
establish
provid
use
tool
explor
mechan
ard
well
screen
therapeut
option
sixweekold
femal
mice
infect
intranas
pfu
viru
infect
mice
show
sign
ill
alter
gait
inact
ruffl
fur
anorexia
day
postinfect
pi
day
pi
bodi
weight
mice
significantli
decreas
figur
day
pi
mice
present
sever
clinic
sign
respiratori
diseas
includ
labor
respir
respiratori
distress
mice
lost
almost
initi
bodi
weight
day
pi
mice
nearli
unabl
respond
exterior
stimuli
acut
respiratori
rate
labor
respir
observ
video
video
control
approxim
mice
die
day
pi
gross
observ
infect
mice
show
lung
highli
edemat
profus
area
hemorrhag
consolid
obviou
gross
lesion
observ
kidney
liver
spleen
brain
infect
mice
mice
infect
pfu
viru
three
mice
euthan
day
pi
viru
titer
viscera
determin
shown
figur
viru
titer
lung
gradual
increas
day
pi
reach
peak
day
pi
viru
titer
lung
gradual
decreas
day
pi
one
three
mice
possess
detect
viru
lung
day
pi
virus
detect
organ
includ
heart
spleen
liver
kidney
blood
brain
indic
time
result
indic
viru
could
replic
effici
mous
lung
caus
system
infect
shown
figur
effect
viral
infect
lung
wet
dri
weight
ratio
chang
significantli
within
day
pi
howev
dramat
increas
observ
day
pi
reach
peak
day
pi
nearli
twice
observ
control
group
lung
chang
lung
wet
weight
bodi
weight
ratio
similar
chang
lung
wet
dri
weight
ratio
figur
result
indic
viru
could
induc
acut
lung
edema
mice
kinet
observ
lung
lesion
mice
shown
figur
day
pi
lung
lesion
character
dropout
mucou
epithelium
inflammatori
cell
adher
bronchiolar
surfac
figur
day
pi
sever
edema
could
seen
around
blood
vessel
figur
interstiti
pneumonia
also
observ
show
interstiti
edema
thicken
alveolar
wall
alveolar
lumen
flood
detach
alveolar
cell
erythrocyt
inflammatori
cell
figur
f
day
pi
viru
caus
sever
interstiti
pneumonia
peribronchiol
character
edema
extens
lymphocyt
neutrophil
plasma
cell
around
area
bronchiol
figur
h
lesion
lung
infect
mice
still
sever
day
pi
extens
alveolar
collaps
remain
alveoli
fill
fibrin
desquam
alveolar
cell
inflammatori
cell
lymphocyt
alveolar
macrophag
predomin
inflammatori
cell
observ
high
magnif
figur
masson
stain
reveal
alveolar
wall
space
fill
collagen
fiber
figur
b
indic
prolif
fibroblast
lesion
may
develop
comparison
lung
mockinfect
control
mice
appar
histolog
chang
mice
inocul
pfu
virus
tissu
collect
indic
time
pi
virus
titrat
mdck
cell
bodi
weight
lung
wet
dri
weight
determin
record
lung
wet
weight
bodi
weight
ratio
lung
wet
dri
weight
ratio
calcul
use
indic
lung
edema
comparison
ratio
obtain
virusinfect
control
group
bar
repres
mean
sd
data
three
mice
immunohistochemistri
reveal
viral
antigen
epitheli
cell
bronchiol
figur
termin
bronchiol
alveolar
epitheli
cell
figur
data
indic
sd
viru
could
infect
epithelia
lower
airway
caus
viral
pneumonia
mice
shown
tabl
virusinfect
mice
show
slightli
decreas
partial
pressur
arteri
oxygen
pa
satur
arteri
oxygen
sa
slightli
increas
partial
pressur
arteri
carbon
dioxid
pa
day
pi
infect
mice
present
sever
clinic
sign
respiratori
distress
day
pi
blood
ga
analysi
also
show
pa
sa
dramat
decreas
compar
control
result
suggest
acut
respiratori
dysfunct
sever
hypoxemia
virusinfect
mice
number
leukocyt
balf
mice
show
increas
day
pi
tabl
balf
virusinfect
mice
day
pi
contain
cellsml
significantli
differ
cellsml
observ
pbsinocul
mice
data
indic
dramat
increas
inflammatori
cell
lung
mice
quantifi
immun
cell
subpopul
respond
viral
infect
next
determin
cell
differenti
count
infect
lung
wright
stain
compar
pbsinocul
anim
mice
infect
viru
exhibit
increas
neutrophil
day
pi
peak
greater
control
group
day
pi
leukopenia
detect
day
pi
statist
signific
day
pi
lowest
valu
appear
day
pi
furthermor
differenti
blood
count
reveal
number
lymphocyt
sharpli
decreas
infect
mice
lowest
number
lymphocyt
observ
occur
day
pi
figur
drop
control
group
number
determin
cytokin
respons
occur
viru
infect
measur
level
five
cytokin
chemokin
lung
infect
mice
day
pi
shown
figur
five
significantli
differ
virusinfect
control
mice
interleukin
il
virusinfect
mice
reach
peak
level
earli
day
pi
significantli
higher
control
group
interferon
ifn
c
monocyt
chemotact
protein
mcp
tumor
necrosi
factor
tnf
dramat
increas
mous
lung
day
pi
consist
appear
pulmonari
lesion
result
show
infect
virus
result
elev
amount
proinflammatori
chemokin
cytokin
lung
mice
spring
novel
influenza
viru
rapidli
spread
worldwid
result
first
influenza
pandem
centuri
critic
ill
case
caus
viru
retrospect
show
progress
die
due
ard
howev
pathogenesi
therapeut
intervent
ard
caus
infect
still
elucid
anim
model
diseas
import
character
pathogenesi
develop
preclin
evid
revis
approach
ventil
patient
ard
present
mous
model
studi
ard
induc
viru
virul
variant
previou
studi
indic
typic
virus
bind
sialic
acid
sa
receptor
sa
receptor
found
mous
respiratori
tract
therefor
typic
viru
may
abl
induc
ard
mice
fact
use
viru
induc
ard
mice
howev
anim
inocul
high
dose
viru
pfu
show
moder
respiratori
symptom
lethal
observ
unpublish
data
shown
viru
possess
mutat
hemagglutinin
ha
could
increas
pathogen
mice
bind
sa
receptor
moreov
clinic
data
indic
variant
associ
sever
human
infect
therefor
suggest
variant
possess
mutat
ha
induc
ard
mous
model
viru
use
present
studi
isol
swine
sequenc
analysi
reveal
eight
gene
isol
close
relationship
influenza
viru
circul
human
notabl
swine
isol
mutat
ha
compar
viru
ld
pfu
show
significantli
increas
virul
mice
ld
pfu
nearli
ident
mouseadapt
strain
ahong
ld
pfu
mice
infect
pfu
sd
viru
show
obviou
respiratori
symptom
includ
visual
promin
sign
respiratori
distress
abdomin
respir
approxim
mortal
day
pi
lung
virusinfect
mice
highli
edemat
also
demonstr
dramat
increas
lung
wet
dri
weight
ratio
patholog
chang
present
progress
pattern
typic
diffus
alveolar
damag
interstiti
alveolar
edema
neutrophil
macrophagedomin
inflammatori
cellular
infiltr
area
hemorrhag
necrot
bronchiol
arteri
blood
ga
satur
key
paramet
ard
human
present
mous
model
pao
sao
infect
mice
significantli
lower
control
group
day
pi
especi
day
pi
paramet
sharpli
decreas
virusinfect
mice
began
die
chang
arteri
blood
ga
demonstr
infect
mice
develop
sever
hypoxemia
consist
appear
clinic
sign
lung
lesion
ard
previou
studi
show
mice
infect
typic
viru
exhibit
mild
interstiti
inflammatori
infiltr
limit
alveol
wherea
sever
lung
damag
found
mice
includ
sever
edema
around
blood
vessel
bronchiol
extens
inflammatori
accumul
day
pi
day
pi
surviv
mice
develop
irrevers
fibrosi
involv
collagen
deposit
alveolar
wall
space
similar
observ
human
ard
patient
infect
histopatholog
result
consist
ard
induc
influenza
virus
mice
infect
mouseadapt
viru
apuerto
high
pathogen
viru
also
show
progress
seri
patholog
chang
interstiti
pneumonia
diffus
alveolar
damag
howev
contrast
highli
pathogen
viru
mice
infect
viru
show
viral
spread
extrapulmonari
organ
immunohistochem
examin
reveal
presenc
viral
antigen
bronchiol
termin
bronchiolar
epithelium
alveolar
epitheli
cell
perhap
viru
infect
alveoli
particularli
type
ii
pneumocyt
rather
bronchiol
key
develop
ard
type
ii
pneumocyt
respons
product
secret
surfact
lower
surfac
tension
water
allow
membran
separ
insuffici
pulmonari
surfact
alveoli
may
result
alveolar
collaps
pandem
high
pathogen
virus
preferenti
infect
type
ii
pneumocyt
alveolar
macrophag
mice
alveolar
macrophag
may
play
critic
role
diseas
pathogenesi
product
infecti
viru
rather
upregul
proinflammatori
cytokin
may
damag
alveolar
pneumocyt
phenomena
suggest
viral
cell
tropism
may
determin
process
ard
pulmonari
aberr
immun
respons
consid
signific
featur
ard
induc
viru
present
mous
model
number
leukocyt
observ
balf
virusinfect
mice
significantli
increas
compar
control
mice
day
pi
differ
count
balf
show
proport
neutrophil
dramat
increas
innat
immun
cell
capabl
reduc
viru
load
lung
howev
could
caus
lung
injuri
direct
indirect
mechan
neutrophil
oxid
proteas
caus
direct
injuri
cell
alveolarcapillari
membran
neutrophil
macrophag
secret
copiou
amount
chemokin
cytokin
recruit
immun
cell
lung
tissu
produc
cytokin
storm
one
import
factor
product
ard
retrospect
cohort
studi
patient
found
higher
level
proinflammatori
cytokin
chemokin
plasma
observ
ardsdeath
group
compar
survivedwithoutard
milddiseas
group
anoth
studi
critic
ill
patient
ard
caus
viru
infect
shown
hallmark
diseas
sever
elev
level
tnfa
examin
level
five
cytokin
chemokin
infect
mous
lung
found
signific
differ
virusinfect
mock
group
prove
high
level
abl
mediat
acut
lung
injuri
neg
correl
pa
fi
ratio
sever
affect
patient
viru
infect
data
show
viral
infect
induc
high
level
mous
lung
may
also
play
import
role
cours
ard
hagau
etc
found
level
tnfa
increas
significantli
ard
patient
present
studi
tnf
level
also
dramat
increas
lung
virusinfect
mice
consist
clinic
symptom
reach
peak
level
mice
began
die
addit
high
level
ifnc
also
present
virusinfect
mous
lung
similar
observ
found
sever
affect
human
infect
summari
success
establish
ard
mous
model
induc
virul
variant
demonstr
key
human
ard
clinic
patholog
featur
respiratori
distress
low
pa
exud
prolif
fibrot
lung
high
level
inflammatori
cell
cytokin
mous
model
may
contribut
studi
pathogenesi
therapi
ard
induc
viru
determin
ld
viru
eight
femal
balbc
mice
per
group
inocul
pfu
ml
virus
monitor
day
valu
calcul
use
spearmankarb
method
express
pfu
per
mld
evalu
pathogen
viru
mice
found
could
effici
replic
lung
mice
high
lethal
pfu
per
mld
determin
optim
dose
inocul
mice
group
infect
pfu
virus
sign
bodi
weight
mortal
monitor
daili
group
day
pilot
experi
indic
dose
pfu
optim
cours
diseas
prolong
mice
present
obviou
sign
respiratori
ill
balbc
mice
lightli
anesthet
inocul
ml
pfu
viru
pb
mockinfect
anim
inocul
ml
pb
indic
time
infect
mice
sacrif
paramet
present
cours
diseas
determin
twenti
mice
infect
viru
inocul
pb
use
investig
clinic
sign
mortal
day
three
mice
euthan
day
pi
organ
collect
collect
tissu
weigh
homogen
prepar
cold
pb
homogen
centrifug
rpm
min
remov
cell
debri
supernat
serial
dilut
viral
titer
determin
plaqu
assay
mdck
cell
viru
titer
express
mean
log
pfug
standard
deviat
sd
three
mice
euthan
day
pi
lung
remov
weigh
desicc
oven
h
lung
wet
weight
bodi
weight
ratio
lung
wet
dri
weight
ratio
calcul
use
indic
lung
edema
previous
describ
three
mice
euthan
day
pi
lung
fix
buffer
formalin
embed
paraffin
section
stain
hematoxylin
eosin
lung
day
pi
also
stain
masson
trichrom
lung
tissu
section
taken
day
pi
stain
influenza
viru
antigen
antiinfluenza
nucleoprotein
monoclon
antibodi
abcam
hong
kong
use
identifi
influenza
viru
nucleoprotein
section
secondari
antibodi
millipor
billerica
usa
primari
antibodi
label
horseradish
peroxidas
color
reaction
develop
horseradish
peroxidas
reaction
kit
diaminobenzidinetetrahydrochlorid
sigma
st
loui
mo
usa
blood
ga
analysi
perform
previous
describ
three
mice
anesthet
zoletil
tiletaminezolazepam
virbac
mgg
day
pi
arteri
blood
sampl
withdrawn
heparin
syring
percutan
left
ventricular
sampl
lightli
anesthet
mice
spontan
breath
room
air
blood
ga
analysi
immedi
perform
use
vetstat
electrolyt
blood
ga
analyz
idexx
laboratori
westbrook
usa
leukocyt
count
balf
perform
previous
describ
briefli
three
mice
euthan
day
pi
lung
lavag
twice
situ
chest
caviti
open
midlin
incis
total
volum
ml
salin
insert
endotrach
tube
rate
recoveri
balf
less
anim
test
amount
fluid
recov
record
aliquot
balf
dilut
crystal
violet
acet
acid
leukocyt
stain
erythrocyt
hemolysi
number
leukocyt
balf
count
hemacytomet
microscop
differenti
count
balf
sampl
mous
stain
wright
stain
number
monocyt
neutrophil
lymphocyt
determin
basi
morpholog
criteria
light
microscop
evalu
least
cell
per
slide
slide
count
twice
differ
observ
blind
statu
anim
heparin
blood
sampl
collect
day
pi
total
number
leukocyt
differenti
blood
count
three
individu
mice
analyz
use
autom
hematolog
analyz
tnf
ifnc
level
determin
lung
homogen
use
cytometr
bead
array
techniqu
bd
cytometr
bead
array
mous
inflamm
kit
bd
bioscienc
san
diego
ca
usa
accord
manufactur
instruct
briefli
ml
mous
inflamm
captur
bead
suspens
ml
pe
detect
reagent
ad
equal
amount
sampl
standard
dilut
incub
h
room
temperatur
dark
subsequ
sampl
wash
ad
ml
wash
buffer
centrifug
g
room
temperatur
min
supernat
discard
ml
wash
buffer
ad
sampl
analyz
bd
facsarray
bioanalyz
bd
bioscienc
accord
manufactur
instruct
standard
curv
prepar
similar
method
data
analyz
use
bd
cba
softwar
bd
bioscienc
final
chemokin
cytokin
level
record
pgml
homogen
data
analyz
twoway
analysi
varianc
use
graphpad
prism
version
graphpad
softwar
san
diego
ca
usa
signific
effect
observ
pairwis
comparison
perform
use
bonferroni
posthoc
test
data
report
mean
sd
